Literature DB >> 27040304

Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis.

Wiebke Schröder1, Harriet Sommer2, Beryl Primrose Gladstone3, Federico Foschi1, Jenny Hellman4, Birgitta Evengard5, Evelina Tacconelli6.   

Abstract

OBJECTIVES: Determinants of inappropriate antibiotic prescription in the community are not clearly defined. The objective of this study was to perform a systematic review and meta-analysis evaluating gender differences in antibiotic prescribing in primary care.
METHODS: All studies analysing antibiotic prescription in primary care were eligible. PubMed and MEDLINE entries with publication dates from 1976 until December 2013 were searched. The primary outcomes were the incidence rate ratio (IRR) (measured as DDD/1000 inhabitants/day) and the prevalence rate ratio (PRR) (measured as prevalence rate/1000 inhabitants) of antimicrobial prescription, stratified by gender, age and antibiotic class. Random-effects estimates of the IRR and PRR and standard deviations were calculated.
RESULTS: Overall, 576 articles were reviewed. Eleven studies, comprising a total of 44 333 839 individuals, were included. The studies used data from prospective national (five studies) or regional (six studies) surveillance of community pharmacy, insurance or national healthcare systems. Women were 27% (PRR 1.27 ± 0.12) more likely than men to receive an antibiotic prescription in their lifetimes. The amount of antibiotics prescribed to women was 36% (IRR 1.36 ± 0.11) higher than that prescribed for men in the 16 to 34 years age group and 40% (IRR 1.40 ± 0.03) greater in the 35 to 54 years age group. In particular, the amounts of cephalosporins and macrolides prescribed to women were 44% (IRR 1.44 ± 0.30) and 32% (IRR 1.32 ± 0.15) higher, respectively, than those prescribed for men.
CONCLUSIONS: This meta-analysis shows that women in the 16 to 54 years age group receive a significantly higher number of prescriptions of cephalosporins and macrolides in primary care than men do. Prospective studies are needed to address reasons for gender inequality in prescription and to determine whether a difference in adverse events, including resistance development, also occurs.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27040304     DOI: 10.1093/jac/dkw054

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  33 in total

Review 1.  Sex disparities matter in cancer development and therapy.

Authors:  Sue Haupt; Franco Caramia; Sabra L Klein; Joshua B Rubin; Ygal Haupt
Journal:  Nat Rev Cancer       Date:  2021-04-20       Impact factor: 60.716

2.  Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.

Authors:  E Forsblom; A Kakriainen; E Ruotsalainen; A Järvinen
Journal:  Infection       Date:  2018-09-07       Impact factor: 3.553

3.  National Estimates of Emergency Department Visits for Antibiotic Adverse Events Among Adults-United States, 2011-2015.

Authors:  Andrew I Geller; Maribeth C Lovegrove; Nadine Shehab; Lauri A Hicks; Mathew R P Sapiano; Daniel S Budnitz
Journal:  J Gen Intern Med       Date:  2018-04-20       Impact factor: 5.128

4.  Gender differences in the use of anti-infective medications before and after widowhood: a register-based study.

Authors:  Adriana Santacroce; Jonas W Wastesson; Andreas Höhn; Kaare Christensen; Anna Oksuzyan
Journal:  J Epidemiol Community Health       Date:  2018-02-19       Impact factor: 3.710

5.  Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients.

Authors:  Patricio González-Hormazábal; Alex Arenas; Carolina Serrano; Margarita Pizarro; Eduardo Fuentes-López; Jorge Arnold; Zoltan Berger; Maher Musleh; Héctor Valladares; Enrique Lanzarini; Lilian Jara; V Gonzalo Castro; M Constanza Camargo; Arnoldo Riquelme
Journal:  Arch Med Res       Date:  2021-02-12       Impact factor: 2.235

6.  Bugs That Can Resist Antibiotics but Not Men: Gender-Specific Differences in Notified Infections and Colonisations in Germany, 2010-2019.

Authors:  Michael Brandl; Alexandra Hoffmann; Niklas Willrich; Annicka Reuss; Felix Reichert; Jan Walter; Tim Eckmanns; Sebastian Haller
Journal:  Microorganisms       Date:  2021-04-22

7.  Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

8.  EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.

Authors:  Nithya Babu Rajendran; Beryl Primrose Gladstone; Jesús Rodríguez-Baño; Frangiscos Sifakis; Andreas Voss; Yehuda Carmeli; Francesco Robert Burkert; Panagiota Gkolia; Evelina Tacconelli
Journal:  BMJ Open       Date:  2017-01-05       Impact factor: 2.692

9.  The Antibiotic Guardian campaign: a qualitative evaluation of an online pledge-based system focused on making better use of antibiotics.

Authors:  Joanna May Kesten; Alex Bhattacharya; Diane Ashiru-Oredope; Maya Gobin; Suzanne Audrey
Journal:  BMC Public Health       Date:  2017-07-11       Impact factor: 3.295

10.  The infant gut resistome is associated with E. coli and early-life exposures.

Authors:  Rebecca M Lebeaux; Modupe O Coker; Erika F Dade; Thomas J Palys; Hilary G Morrison; Benjamin D Ross; Emily R Baker; Margaret R Karagas; Juliette C Madan; Anne G Hoen
Journal:  BMC Microbiol       Date:  2021-07-02       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.